Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2000
02/10/2000WO2000006698A1 98 human secreted proteins
02/10/2000WO2000006605A2 Heterominibodies
02/10/2000WO2000006603A1 Antibody for detecting microorganism
02/10/2000WO2000006601A1 Isoforms of human calcium sensing receptor
02/10/2000WO2000006600A1 Human mink gene mutations associated with arrhythmia
02/10/2000WO2000006599A1 Inhibitors of hiv membrane fusion
02/10/2000WO2000006598A1 Endogenous retrovirus tumor associated nucleic acids and antigens
02/10/2000WO2000006597A2 Endogenous constitutively activated g protein-coupled orphan receptors
02/10/2000WO2000006593A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
02/10/2000WO2000006592A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
02/10/2000WO2000006589A1 Prostate derived ets factor
02/10/2000WO2000006525A2 Synthesis of combinatorial libraries of compounds reminiscent of natural products
02/10/2000WO2000006306A1 Method and device for optimising lacquers
02/10/2000WO2000006243A2 Absorbable brachytherapy and chemotherapy delivery devices and methods
02/10/2000WO2000006206A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
02/10/2000WO2000006199A1 Kvlqt1 - a long qt syndrome gene
02/10/2000WO2000006187A2 Modulation of apoptosis
02/10/2000WO2000006183A1 C7F2-A NOVEL POTASSIUM CHANNEL β-SUBUNIT
02/10/2000WO2000006170A1 Inhibitors of herpesvirus gene expression, replication and pathogenesis
02/10/2000WO2000006164A1 Benzothiazole dioxetanes
02/10/2000WO2000006014A1 Method for marking red blood cells using a water-soluble fluorescent colouring agent
02/10/2000WO2000005943A1 A device for and a method of detecting a disease of the udder of an animal
02/10/2000WO2000000829A3 Method and composition to detect c-type retroviral infection
02/10/2000WO2000000825A3 Detection and modulation of cellular immunity to immune privileged antigens
02/10/2000WO1999067254A3 Multi-drug resistant retroviral protease inhibitors and use thereof
02/10/2000WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors
02/10/2000WO1999063939A3 Multibinding inhibitors of cyclooxygenase-2
02/10/2000WO1999061600A3 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
02/10/2000WO1999060371A3 Method and apparatus for detecting hazardous agents
02/10/2000WO1999058678A3 Antibodies to dendritic cells and human dendritic cell populations and uses thereof
02/10/2000WO1999055837A3 Improvements in or relating to separation processes
02/10/2000WO1999054728A3 Method of predicting receptor modulating activity
02/10/2000WO1999054494A3 Multiparameter facs assays to detect alterations in cellular parameters
02/10/2000WO1999053038A3 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
02/10/2000WO1999049039A3 GFRα3 AND ITS USES
02/10/2000WO1999049038A3 Human calcium-binding proteins
02/10/2000WO1999045389A3 Ligand screening and design by x-ray crystallography
02/10/2000WO1999045116A3 Human homolog of a nuclear migration gene and its use
02/10/2000WO1999042481A3 AGENTS FOR TREATING HUMAN ILLNESSES BASED ON β-CATENIN, AND THE PRODUCTION AND USE THEREOF
02/10/2000WO1999041376A3 Retinoblastoma protein complexes and retinoblastoma interacting proteins
02/10/2000WO1999023104A3 Antitumour uridine analogues
02/10/2000DE19835721A1 Verfahren zur Bestimmung der Immunabwehr des Blutes sowie Testkit hierfür und Verwendung eines geeigneten Spritzenzylinders A method for determining the immune response of the blood and test kit therefor, and use of an appropriate syringe barrel
02/10/2000DE19834938A1 Verfahren zur kosmetischen Bräunungsbestimmung einer Selbstbräunungszusammensetzung und Test-Kit Process for cosmetic tanning determining a self-tanning composition and test kit
02/10/2000DE19833991A1 Arrangement for detecting gaseous component in gas flow, e.g. alcohol in breath; has choke in sample extraction line, pressure sensor on upstream side of choke, flow detector for generating null flow signal
02/10/2000DE19833453A1 Vorrichtung und Betriebsverfahren an/in geheizten Gassensoren zur Minimierung von Leckstrom-Einflüssen Apparatus and method of operation of / in heated gas sensors to minimize leakage current influences
02/10/2000DE19822823A1 Neue Peptidfragmente zur Reinigung von Proteinen New peptide fragments in protein purification
02/10/2000CA2776054A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
02/10/2000CA2340855A1 Granulocytic ehrlichia genes and uses thereof
02/10/2000CA2339301A1 Hdpbo81 nucleic acids and polypeptides
02/10/2000CA2339121A1 Arrayed biomolecules and their use in sequencing
02/10/2000CA2339096A1 Modulation of apoptosis
02/10/2000CA2339016A1 Nucleic acid labeling compounds
02/10/2000CA2338883A1 Benzothiazole dioxetanes
02/10/2000CA2338783A1 Electrostatic device and method for immunological detection
02/10/2000CA2338675A1 Spectral topography of mammalian matter
02/10/2000CA2338643A1 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof
02/10/2000CA2338565A1 Method and device for optimising lacquers
02/10/2000CA2338247A1 General screening method for ligand-protein interactions
02/10/2000CA2338022A1 Inhibitors of hiv membrane fusion
02/10/2000CA2338019A1 Prostate derived ets factor
02/10/2000CA2337493A1 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000CA2337492A1 Delta-related polypeptides
02/10/2000CA2337335A1 Method to predict and/or control the strength properties of a foil-like material
02/10/2000CA2337320A1 Method for marking red blood cells using a water-soluble fluorescent colouring agent
02/10/2000CA2337102A1 Nucleic acids and proteins from group b streptococcus
02/10/2000CA2337092A1 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000CA2337086A1 Eukaryotic cell-based gene interaction cloning
02/10/2000CA2336708A1 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000CA2336543A1 Isoforms of human calcium sensing receptor
02/10/2000CA2336539A1 Reversible inhibiting probes
02/10/2000CA2336534A1 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000CA2336532A1 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000CA2336530A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
02/10/2000CA2336263A1 Kvlqt1 - a long qt syndrome
02/10/2000CA2335643A1 C7f2-a novel potassium channel .beta.-subunit
02/10/2000CA2335376A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
02/10/2000CA2335320A1 Nucleic acids encoding proteins involved in sensory transduction
02/10/2000CA2335092A1 Method for identification and isolation of hematopoietic progenitor cells
02/09/2000EP0978724A1 Reagent for the assay of hemoglobin and the determination of leukocytes in a blood sample
02/09/2000EP0978723A2 Method for predicting the compressive strength of concrete and mortar containing fly ash
02/09/2000EP0978717A1 Plate glass shatter testing method, device, imaging method for glass testing and image signal processing method
02/09/2000EP0978570A2 Detecting mycobacterium tuberculosis by nucleic acid sequence amplification
02/09/2000EP0978568A2 Method for the prevention of hemoglobin interference in reagent systems for measuring peroxidase activity
02/09/2000EP0978564A1 Recombinant fusion proteines based on bacterial adhesines for diagnostic assays
02/09/2000EP0978559A2 Induction of tumour immunity by redirection of tumour cells against antigen presenting cells
02/09/2000EP0977996A1 Analysis system
02/09/2000EP0977995A1 Method for the functional detection of disorders in the protein c system
02/09/2000EP0977994A1 Method for the identification and characterization of nuclear receptor ligands
02/09/2000EP0977993A1 Cadherin-11 as an indicator of viable pregnancy
02/09/2000EP0977992A1 Detection of intracellular ligand binding
02/09/2000EP0977991A1 Monoclonal antibodies to human cd6
02/09/2000EP0977988A1 Homogeneous fluorescence assay for measuring the effect of compounds on gene expression
02/09/2000EP0977986A1 Methods for applying a reagent to an analytical test device
02/09/2000EP0977985A1 Method of determining three-dimensional protein structure from primary protein sequence
02/09/2000EP0977896A1 Diagnostic system and method for determining the presence of a genotoxic compound in a sample
02/09/2000EP0977893A1 Reagents and methods useful for detecting diseases of the prostate
02/09/2000EP0977887A2 Member of the tnf family useful for treatment and diagnosis of disease
02/09/2000EP0977857A1 Human c-maf compositions and methods of use thereof
02/09/2000EP0977856A1 Lag-3 splice variants
02/09/2000EP0977849A1 Leukemia associated genes
1 ... 3145 3146 3147 3148 3149 3150 3151 3152 3153 3154 3155 3156 3157 3158 3159 3160 3161 3162 3163 3164 3165 ... 3937